Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV Control

Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV Control

Hepatocellular carcinoma (HCC) incidence has dramatically decreased in patients infected with HCV and HBV due to the widespread use of highly effective antiviral agents. Nevertheless, a substantial proportion of patients with advanced fibrosis or cirrhosis following HCV clearance of in case of HBV c...

Full description

Bibliographic Details
Main Authors:	Pierre Nahon, Erwan Vo Quang, Nathalie Ganne-Carrié
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Series:	Journal of Clinical Medicine
Subjects:	viral hepatitis hepatocellular carcinoma antivirals risk scores surveillance
Online Access:	https://www.mdpi.com/2077-0383/10/2/353

Similar Items

Efficacy of antiviral therapy in hepatocellular carcinoma patients with high HBV-DNA levels after radical resection
by: DING Chen
Published: (2014-07-01)

Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals
by: Tatsuya Minami, et al.
Published: (2021-06-01)

Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection
by: Jian-Lin Chen, et al.
Published: (2016-03-01)

Antiviral therapy and risk for hepatocellular carcinoma in chronic viral hepatitis
by: D T Abdurakhmanov
Published: (2013-10-01)

Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy
by: Sun X, et al.
Published: (2020-12-01)

Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy
by: Ming‐Lun Yeh, et al.
Published: (2021-02-01)

Treatment of patients with HBV cirrhosis: Successes, unsolved problems
by: I G Bakulin, et al.
Published: (2013-12-01)

Better prognosis of hepatic resection combined with antiviral therapy for HBV-related hepatocellular carcinoma with BCLC Stage B/C
by: Qin Wei, et al.
Published: (2017-11-01)

HCV-Specific T Cell Responses During and After Chronic HCV Infection
by: Hendrik Luxenburger, et al.
Published: (2018-11-01)

A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma
by: Suofeng Sun, et al.
Published: (2019-10-01)

Effects of Antiviral Therapy on HBV Reactivation and Survival in Hepatocellular Carcinoma Patients Undergoing Hepatic Artery Infusion Chemotherapy
by: Shousheng Liu, et al.
Published: (2021-02-01)

Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma
by: Hiotis Spiros P, et al.
Published: (2012-06-01)

ERADICATION OF HCV INFECTION IN PATIENTS WITH LIVER CIRRHOSIS: FACTOR OF CANCER PREVENTION OR CARCINOGENESIS?
by: N. A. Malinina, et al.
Published: (2019-06-01)

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
by: Ioannis Varbobitis, et al.
Published: (2016-09-01)

Successful antiviral therapy for chronic hepatitis C in a patient after surgery for hepatocellular carcinoma (a clinical observation)
by: I. G. Nikitin, et al.
Published: (2018-08-01)

Recent Advances in HBV and HCV Immunology
by: Lynn B Dustin, et al.
Published: (2015-09-01)

Hepatitis B viral load and risk of HBV-related liver disease: from East to West?
by: Soeradj Harkisoen, M.D., et al.
Published: (2012-03-01)

Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
by: Jaemin Lee, et al.
Published: (2016-09-01)

Long Term Efficacy of Antiviral Therapy: Mortality and Incidence of Hepatocellular Carcinoma
by: Hyun Woong Lee
Published: (2019-11-01)

The Mechanisms of HBV-Induced Hepatocellular Carcinoma
by: Jiang Y, et al.
Published: (2021-05-01)

Nomogram for prediction of the international study Group of Liver Surgery (ISGLS) grade B/C Posthepatectomy liver failure in HBV-related hepatocellular carcinoma patients: an external validation and prospective application study
by: Jia-zhou Ye, et al.
Published: (2020-10-01)

The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
by: Lee HW, et al.
Published: (2021-05-01)

Study of liver in HBV-related hepatocellular carcinoma: Stereology shows quantitative differences in liver structure
by: Bita Moudi, et al.
Published: (2018-09-01)

Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma recurrence
by: Nevine Ibrahim Musa, et al.
Published: (2020-07-01)

The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophiliaHCC after HCV eradication in hemophilia
by: Yosuke Inukai, et al.
Published: (2022-01-01)

Immunological Mechanisms for Hepatocellular Carcinoma Risk after Direct-Acting Antiviral Treatment of Hepatitis C Virus Infection
by: Pil Soo Sung, et al.
Published: (2021-01-01)

Danazol improves thrombocytopenia in HCV patients treated with peginterferon and ribavirin
by: Guillermo Cabrera Álvarez, et al.
Published: (2011-10-01)

Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
by: Mi Young Jeon, et al.
Published: (2021-04-01)

Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Dual Infection
Published: (2006-04-01)

Eradication of Hepatitis C Virus (HCV) Improves Survival of Hepatocellular Carcinoma Patients with Active HCV Infection – A Real-World Cohort Study
by: Luo Y, et al.
Published: (2020-07-01)

Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
by: Hye Won Lee, et al.
Published: (2020-11-01)

Hepatitis C Virus Elimination Using Direct Acting Antivirals after the Radical Cure of Hepatocellular Carcinoma Suppresses the Recurrence of the Cancer
by: Arinaga-Hino, T., et al.
Published: (2022)

Chronic hepatitis B exhibited higher rate of hepatocellular carcinoma occurrence than hepatitis C in cirrhotic patients after effective antiviral treatment
by: Ming-Tsung Lin, et al.
Published: (2021-01-01)

Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B
by: Lilian Yan Liang, et al.
Published: (2021-07-01)

A Decade-old Change in the Screening Rate for Hepatocellular Carcinoma Among a Hepatitis B Virus-infected Population in Korea
by: Hee Yeon Kim, et al.
Published: (2016-01-01)

Glomerular diseases associated with HBV and HCV infection
by: Boriana Kiperova
Published: (2014-03-01)

Influence of viral hepatitis status on prognosis in patients undergoing hepatic resection for hepatocellular carcinoma: a meta-analysis of observational studies
by: Li Bin, et al.
Published: (2011-09-01)

Comparison of the efficacy and safety of direct-acting antiviral therapy with or without hepatitis C-related hepatocellular carcinoma
by: Byung Soo Kwan, et al.
Published: (2021-03-01)

Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C
by: Eiichi Ogawa, et al.
Published: (2020-09-01)

Long-Term Surgical Outcomes of Liver Resection for Hepatocellular Carcinoma in Patients With HBV and HCV Co-Infection: A Multicenter Observational Study
by: Hang-Dong Jia, et al.
Published: (2021-07-01)